6500 Transcanada hwy
Suite 400
Pointe-Claire, QC H9R 0A5
Canada
514-928-7368
https://wuhn.org
Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 700
Name | Title | Pay | Exercised | Year born |
---|---|---|---|---|
Ms. Carol Pan | Principal Financial Officer, Principal Accounting Officer and Treasurer | 60k | N/A | 1984 |
Mr. Jeffrey Robinson | Founder, Chairman & CEO | N/A | N/A | N/A |
Mr. Willem Jonker | Chief Operating Officer | N/A | N/A | N/A |
Dr. Hyder Ali Khoja A.Ag., M.Sc., Ph.D. | Chief Scientific Officer | N/A | N/A | N/A |
Ms. Shivani Subudhi | Head of Marketing | N/A | N/A | N/A |
Mr. Huang Zhaoqi | Vice General Manager of Turbine and Director | N/A | N/A | 1962 |
Dr. Anna Leralta Morera | Chief Medical Officer | N/A | N/A | N/A |
Mr. Samuel Williams | Head of Food Formulations & Functional Foods | N/A | N/A | N/A |
Ms. Clementine Toto | Head of African Aromatherapy | N/A | N/A | N/A |
Nicola Royce | Managing Director of M2Biome | N/A | N/A | N/A |
Wuhan General Group (China), Inc., through its subsidiaries, researches, develops, and commercializes a range of cannabidiol (CBD)-based products under the Dr. AnnaRx brand for pharmacies. It also focuses on exploring and developing other indications for psilocybin new therapies that will enable patients who suffer from mental illness. The company offers its products for medical applications, including cancer, mental disorders, chronic pain, and others. Wuhan General Group (China), Inc. is headquartered in Pointe-Claire, Canada.
Wuhan General Group (China), Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.